Jiangsu Hengrui Medicine
600276.SS
#476
Rank
C$73.76 B
Marketcap
C$11.11
Share price
-2.66%
Change (1 day)
2.10%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2026 (TTM): C$0.20

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is C$0.21. In 2025 the company made an earnings per share (EPS) of C$0.24 an increase over its 2024 EPS that were of C$0.19.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$0.20-14.48%
2025C$0.2424.14%
2024C$0.1942.43%
2023C$0.148.77%
2022C$0.12-20.62%
2021C$0.16-26.59%
2020C$0.2127.24%
2019C$0.1728.41%
2018C$0.1320.04%
2017C$0.1131.21%
2016C$0.0830411.46%
2015C$0.0745036.27%
2014C$0.0546719.77%
2013C$0.0456518.05%
2012C$0.0386723.9%
2011C$0.0312126.9%
2010C$0.0245912.37%
2009C$0.0218956.6%
2008C$0.013989.18%
2007C$0.01280114.48%
2006C$0.00596964.83%
2005C$0.00362135.55%
2004C$0.00267129.73%
2003C$0.00205919.86%
2002C$0.001718-2.71%
2001C$0.0017661.02%
2000C$0.001748